About Us
GX Vehicles
- GX Acquisition Corp. II raised $300 million in March 2021 to effect a business combination.
- GX Acquisition Corp. raised $287.5 million in May 2019 to effect a business combination. The SPAC announced a definitive agreement with Celularity, a next-generation biotechnology company creating off-the-shelf cellular medicines for cancer, infectious diseases, and degenerative diseases, on January 8, 2021.
History
- Led by Jay R. Bloom, Dean C. Kehler and Michael G Maselli, veteran investors with more than 30 years of experience each.
- Messrs. Bloom and Kehler are co-founders of Trimaran Capital Partners, and were Vice-Chairmen of CIBC World Markets, Canadian Imperial Bank of Commerce’s global corporate and investment bank, where they were joined by Mr Maselli.
- Trimaran private equity funds have invested approximately $1.75 billion in over 60 acquisition and other private equity transactions. Trimaran has also managed various fixed income investment and hedge fund vehicles.
Expertise
- Dozens of transactions in diverse industries including technology, infrastructure, telecom/media, energy, consumer products and services, financial services, and manufacturing.
- Substantial experience creating and building more than a dozen public companies.
- History of success investing in traditional businesses with new business models.
- GX Acquisition Corp has entered into a definitive SPAC agreement with Celularity.
- Significant network of potential SPAC opportunities and intermediaries identified.
- Work with over 50 institutional investors in sourcing deals.
Team
- Our officers have worked together cohesively for over 20 years.
- Highly experienced board also has a major investment in GX.
Objective
- To complete an initial business combination with a company that has an enterprise value in excess of $1.25 billion, that we believe can grow revenue and earnings materially, and that will be a great public company and drive significant public investor interest.
- Initial focus will be on three areas: (i) Companies that achieve growth through the application of technology, including late stage venture companies; (ii) Companies with growth infrastructure opportunities (iii) Traditional businesses with a bias toward demonstrated or expected growth.